Innoviva

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Innoviva and other ETFs, options, and stocks.

About INVA

Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. 

CEO
Pavel Raifeld
CEOPavel Raifeld
Employees
127
Employees127
Headquarters
Burlingame, California
HeadquartersBurlingame, California
Founded
1996
Founded1996
Employees
127
Employees127

INVA Key Statistics

Market cap
1.15B
Market cap1.15B
Price-Earnings ratio
51.09
Price-Earnings ratio51.09
Dividend yield
—
Dividend yield—
Average volume
922.52K
Average volume922.52K
High today
$18.62
High today$18.62
Low today
$18.27
Low today$18.27
Open price
$18.55
Open price$18.55
Volume
505.00K
Volume505.00K
52 Week high
$21.28
52 Week high$21.28
52 Week low
$14.90
52 Week low$14.90
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.